NEW YORK (GenomeWeb) – Fluidigm reported after the close of the market Thursday that its first quarter revenues decreased 1 percent year over year due primarily to sagging instrument revenue.

For the three months ended March 31, the South San Francisco, California-based life science research tools firm logged $25.2 million in revenues compared to $25.5 million in the year-ago quarter. This included $20.5 million in product revenue and $4.8 million in service revenue.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.